104 related articles for article (PubMed ID: 6276064)
21. Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.
Seymour AA; Sheldon JH; Smith PL; Asaad M; Rogers WL
J Pharmacol Exp Ther; 1994 Apr; 269(1):263-70. PubMed ID: 8169834
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of angiotesin-converting enzyme by quercetin alters the vascular response to brandykinin and angiotensin I.
Häckl LP; Cuttle G; Dovichi SS; Lima-Landman MT; Nicolau M
Pharmacology; 2002 Aug; 65(4):182-6. PubMed ID: 12174832
[TBL] [Abstract][Full Text] [Related]
23. A bradykinin antagonist abolishes beneficial effect of captopril on duration of survival after acute coronary artery ligation in hypertensive rats.
Sharma JN; Abbas SA
Pharmacol Res; 2005 Sep; 52(3):211-5. PubMed ID: 16026715
[TBL] [Abstract][Full Text] [Related]
24. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition.
Kiowski W; Linder L; Kleinbloesem C; van Brummelen P; Bühler FR
Circulation; 1992 Jan; 85(1):1-8. PubMed ID: 1728438
[TBL] [Abstract][Full Text] [Related]
25. Converting enzyme inhibitors and the role of the sulfhydryl group in the potentiation of exo- and endogenous nitrovasodilators.
van Gilst WH; de Graeff PA; de Leeuw MJ; Scholtens E; Wesseling H
J Cardiovasc Pharmacol; 1991 Sep; 18(3):429-36. PubMed ID: 1720843
[TBL] [Abstract][Full Text] [Related]
26. Studies of the effects of insulin, bradykinin, and captopril on blood glucose levels of alloxan-diabetic rats.
Jaffa AA; Pratt J; Ashford A; Bailey GS
Adv Exp Med Biol; 1986; 198 Pt B():373-8. PubMed ID: 3028079
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and pharmacological screening of new angiotensin converting enzyme inhibitors.
Gubert S; Braso MA; Sacristán A; Ortiz JA
Farmaco; 1990 Jan; 45(1):59-79. PubMed ID: 2186741
[TBL] [Abstract][Full Text] [Related]
28. Vasodepressor property of the converting enzyme inhibitor captopril (SQ 14 225): the role of factors other than renin-angiotensin blockade in the rat.
Marks ES; Bing RF; Thurston H; Swales JD
Clin Sci (Lond); 1980 Jan; 58(1):1-6. PubMed ID: 6986224
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin II type 2 receptor-mediated and nitric oxide-dependent renal vasodilator response to compound 21 unmasked by angiotensin-converting enzyme inhibition in spontaneously hypertensive rats in vivo.
Brouwers S; Smolders I; Massie A; Dupont AG
Hypertension; 2013 Nov; 62(5):920-6. PubMed ID: 24041944
[TBL] [Abstract][Full Text] [Related]
30. The role of endogenous bradykinin in blood pressure homeostasis in spontaneously hypertensive rats.
Holte HR; Bjørnstad-Ostensen A; Berg T
Br J Pharmacol; 1996 Aug; 118(8):1925-30. PubMed ID: 8864525
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin-(1-7) antagonist A-779 attenuates the potentiation of bradykinin by captopril in rats.
Maia LG; Ramos MC; Fernandes L; de Carvalho MH; Campagnole-Santos MJ; Souza dos Santos RA
J Cardiovasc Pharmacol; 2004 May; 43(5):685-91. PubMed ID: 15071356
[TBL] [Abstract][Full Text] [Related]
32. A new bradykinin-potentiating peptide (peptide P) isolated from the venom of Bothrops jararacussu (jararacuçu tapete, urutu dourado).
Ferreira LA; Henriques OB; Lebrun I; Batista MB; Prezoto BC; Andreoni AS; Zelnik R; Habermehl G
Toxicon; 1992 Jan; 30(1):33-40. PubMed ID: 1595077
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of beta-adrenergic receptor upregulation induced by ACE inhibition in cultured neonatal rat cardiac myocytes: roles of bradykinin and protein kinase C.
Yonemochi H; Yasunaga S; Teshima Y; Iwao T; Akiyoshi K; Nakagawa M; Saikawa T; Ito M
Circulation; 1998 Jun; 97(22):2268-73. PubMed ID: 9631877
[TBL] [Abstract][Full Text] [Related]
34. Converting enzyme inhibition in the rat by captopril is accompanied by potentiation of carrageenin-induced inflammation.
Boura AL; Svolmanis AP
Br J Pharmacol; 1984 May; 82(1):3-8. PubMed ID: 6329390
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin converting enzyme inhibitors, captopril and enalaprilat, augment bradykinin-induced prostacyclin synthesis in cultured rat vascular smooth muscle cells.
Takeuchi K; Abe K; Sato M; Yasujima M; Omata K; Kasai Y; Kanazawa M; Fang SN; Yoshinaga K
Adv Exp Med Biol; 1989; 247B():489-94. PubMed ID: 2558520
[No Abstract] [Full Text] [Related]
36. Role of kinins in the acute antihypertensive effect of enalapril in hypertensive rats.
Salgado MC; Name CF
Braz J Med Biol Res; 1994 Jun; 27(6):1391-401. PubMed ID: 7894353
[TBL] [Abstract][Full Text] [Related]
37. Effects of captopril on responses to bradykinin in the hindquarters vascular bed of the rat.
Nossaman BD; Kaye AD; Kang B; Feng CJ; Kadowitz PJ
Peptides; 1997; 18(4):491-4. PubMed ID: 9210166
[TBL] [Abstract][Full Text] [Related]
38. Long-term feeding with bioactive tripeptides in aged hypertensive and normotensive rats: special focus on blood pressure and bradykinin-induced vascular reactivity.
Siltari A; Roivanen J; Korpela R; Vapaatalo H
J Physiol Pharmacol; 2017 Jun; 68(3):407-418. PubMed ID: 28820397
[TBL] [Abstract][Full Text] [Related]
39. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
[TBL] [Abstract][Full Text] [Related]
40. Converting enzyme inhibition and vascular prostacyclin synthesis: effect of kinin receptor antagonism.
Hoffmann G; Pietsch R; Göbel BO; Weisser B; Bönner G; Vetter H; Düsing R
Eur J Pharmacol; 1990 Mar; 178(1):79-83. PubMed ID: 2158900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
